ArticleFrontiers in neuroscience2026
Machine learning methods evaluation for identification of cognitive phenotypes in multiple sclerosis and their MRI correlates.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cognitive impairment (CI) is common in multiple sclerosis (MS) yet poorly captured by conventional disability scales. Although neuropsychological assessment and magnetic resonance imaging (MRI) are routinely used separately, there is no simple clinically applicable framework integrating cognitive performance with structural brain changes to identify patients at increased risk of cognitive decline. Integrating neuropsychological testing with MRI-based atrophy metrics may yield clinically useful cognitive phenotypes with differential patterns of brain atrophy measures. Methods: Data were collected from 79 patients with multiple sclerosis (PwMS) who underwent comprehensive neuropsychological assessment and brain MRI. Neuropsychological variables were subjected to a feature selection procedure based on variance and quartile coefficient of dispersion filtering, followed by Pearson correlation and mutual information (MI) analyses to generate reduced feature sets. These feature sets were used as input for unsupervised clustering with the Partitioning Around Medoids (PAM) algorithm to identify cognitive phenotypes. Differences between the resulting groups in the degree of brain atrophy measures were subsequently evaluated using appropriate statistical tests-one-way ANOVA or the Kruskal-Wallis test. Results: The feature selection procedure based on variance and mutual information identified neuropsychological features that were subsequently used for clustering. Based on these features, the PAM algorithm identified three distinct groups of PwMS that differed in their clinical characteristics, degree of brain atrophy measures, and cognitive phenotype, ranging from preserved cognition to global cognitive impairment. Conclusion: Three cognitive phenotypes with differential patterns of brain atrophy measures integrate neuropsychological testing with MRI measures into a clinically applicable framework that may help bridge the gap between structural imaging findings and everyday cognitive assessment in PwMS. This approach may improve screening, enable earlier detection of CI, improve monitoring, and provide valuable information for rehabilitation planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.